C.M. Bidwell & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.2K Hold
566
0.02% 229
2026
Q1
$54.7K Sell
566
-183
-24% -$18.8K 0.03% 218
2025
Q4
$79.5K Sell
749
-1,349
-64% -$156K 0.04% 203
2025
Q3
$266K Buy
2,098
+277
+15% +$33K 0.13% 102
2025
Q2
$223K Buy
1,821
+1,086
+148% +$124K 0.12% 121
2025
Q1
$74.4K Sell
735
-15
-2% -$1.47K 0.04% 183
2024
Q4
$69.3K Buy
750
+318
+74% +$31.2K 0.04% 209
2024
Q3
$41.7K Sell
432
-83
-16% -$7.46K 0.03% 233
2024
Q2
$44.2K Hold
515
0.03% 232
2024
Q1
$42.5K Hold
515
0.03% 232
2023
Q4
$34.4K Hold
515
0.03% 249
2023
Q3
$34.6K Buy
+515
New +$35.4K 0.03% 312
2021
Q4
Sell
-2,828
Closed -$169K 570
2021
Q3
$169K Hold
2,828
0.11% 181
2021
Q2
$176K Buy
+2,828
New +$188K 0.12% 169

Other funds holding EHC

C.M. Bidwell & Associates's EHC Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Encompass Health (EHC) position steady in Q2 2026 at 566 shares worth $57.2K. The position accounts for 0.02% of the portfolio, ranked #229.

C.M. Bidwell & Associates first reported a position in EHC in Q2 2021 and has held it in 14 quarters since. The position peaked at $266K in Q3 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • C.M. Bidwell & Associates held 566 shares of Encompass Health worth $57.2K as of Q2 2026.
  • C.M. Bidwell & Associates left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up 0.02% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #229 holding.
  • C.M. Bidwell & Associates first reported a position in Encompass Health in Q2 2021 and has held it in 14 quarters since.
  • C.M. Bidwell & Associates's Encompass Health position peaked at $266K in Q3 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.